84 related articles for article (PubMed ID: 8112716)
1. Variability of serum human growth hormone levels in different commercial assays: specificity of growth hormone-releasing hormone stimulation.
Chevenne D; Beau N; Léger J; Porquet D
Horm Res; 1993; 40(5-6):168-72. PubMed ID: 8112716
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of four human growth hormone (hGH) immunoassay kits and analysis of recognition of circulating forms].
Gervasi G; Samy M; Scholler R
Pathol Biol (Paris); 1990 Nov; 38(9):912-9. PubMed ID: 2277723
[TBL] [Abstract][Full Text] [Related]
3. Influence of matrix on concentrations of somatotropin measured in serum with commercial immunoradiometric assays.
Felder RA; Holl RW; Martha P; Bauler G; Hellman P; Wills MR; Thorner MO
Clin Chem; 1989 Jul; 35(7):1423-6. PubMed ID: 2758587
[TBL] [Abstract][Full Text] [Related]
4. [Serum human growth hormone assay. Comparison of six assay kits].
Chabert-Orsini V; Simonin G; Brue T; Conte-Devolx B; Carayon P
Ann Endocrinol (Paris); 1992; 53(4):153-7. PubMed ID: 1305801
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone.
Gil-Ad I; Klinger B; Pertzelan A; Erster B; Silbergeld A; Talpaz H; Laron Z
J Endocrinol Invest; 1992 Nov; 15(10):735-9. PubMed ID: 1362733
[TBL] [Abstract][Full Text] [Related]
6. Isotopic and nonisotopic assays for measuring somatotropin compared: re-evaluation of cutoff value in provocative tests.
Banfi G; Marinelli M; Casari E; Murone M; Bonini P
Clin Chem; 1991 Feb; 37(2):273-6. PubMed ID: 1993338
[TBL] [Abstract][Full Text] [Related]
7. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
Tapanainen P; Knip M; Lautala P; Leppäluoto J
J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
[TBL] [Abstract][Full Text] [Related]
8. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
Donnadieu M; Evain-Brion D; Tonon MC; Vaudry H; Job JC
J Clin Endocrinol Metab; 1985 Jun; 60(6):1132-4. PubMed ID: 3923020
[TBL] [Abstract][Full Text] [Related]
9. Performance of proficiency survey samples in two immunoradiometric assays of human growth hormone and comparison with patients' samples.
Pringle PJ; Jones J; Hindmarsh PC; Preece MA; Brook CG
Clin Chem; 1992 Apr; 38(4):553-7. PubMed ID: 1568321
[TBL] [Abstract][Full Text] [Related]
10. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?
Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P; Eggermont E
J Clin Endocrinol Metab; 1990 May; 70(5):1445-51. PubMed ID: 2186059
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of the gonadotropic hormone releasing hormone (GHRH) test in the diagnosis of growth deficiency].
Hümmelink R; Sippell WG
Monatsschr Kinderheilkd; 1988 Sep; 136(9):618-21. PubMed ID: 3070368
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
[TBL] [Abstract][Full Text] [Related]
13. Reduction of the effects of growth hormone release inhibiting factor enhances plasma growth hormone response to GHRH.
Shi YF; Fang XD
Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(1):13-8. PubMed ID: 2565570
[TBL] [Abstract][Full Text] [Related]
14. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
Schmitt K; Schober E; Birnbacher R; Frisch H
Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of GH-releasing hormone and GH during human pregnancy.
Mazlan M; Spence-Jones C; Chard T; Landon J; McLean C
J Endocrinol; 1990 Apr; 125(1):161-7. PubMed ID: 2110964
[TBL] [Abstract][Full Text] [Related]
16. Variability in the quantitation of circulating growth hormone using commercial immunoassays.
Celniker AC; Chen AB; Wert RM; Sherman BM
J Clin Endocrinol Metab; 1989 Feb; 68(2):469-76. PubMed ID: 2918055
[TBL] [Abstract][Full Text] [Related]
17. Assay-dependent results of immunoassayable spontaneous 24-hour growth hormone secretion in short children.
Granada ML; Sanmartí A; Lucas A; Salinas I; Carrascosa A; Foz M; Audí L
Acta Paediatr Scand Suppl; 1990; 370():63-70; discussion 71. PubMed ID: 2260460
[TBL] [Abstract][Full Text] [Related]
18. Development of an in-house radioimmunoassay for human growth hormone.
Wan Nazaimoon WM; Satgunasingam N; Khalid B
Malays J Pathol; 1990 Jun; 12(1):13-20. PubMed ID: 2090885
[TBL] [Abstract][Full Text] [Related]
19. Insulinhypoglycemia but not arginine infusion stimulates circulating plasma growth hormone-releasing hormone (GHRH) concentrations in children.
Rosskamp R; Schmid G; Klumpp J; Tegeler A
Horm Metab Res; 1987 Sep; 19(9):434-6. PubMed ID: 3121486
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of monomeric and dimeric biosynthetic human growth hormone in commercial immunoassays.
Bowsher RR; Apathy JM; Ferguson AL; Riggin RM; Henry DP
Clin Chem; 1990 Feb; 36(2):362-6. PubMed ID: 2302782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
